ziftomenib
Showing 1 - 4 of 4
Acute Lymphoblastic Leukemia, With Appropriate Mutations, Acute Myeloid Leukemia, With NPM1 Mutations Trial (ziftomenib)
Available
- Acute Lymphoblastic Leukemia, With Appropriate Mutations
- Acute Myeloid Leukemia, With NPM1 Mutations
- ziftomenib
- (no location specified)
Feb 10, 2023
AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)
Not yet recruiting
- AML
- +11 more
- Ziftomenib
- +5 more
- (no location specified)
Aug 14, 2023
Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,
Not yet recruiting
- Acute Myeloid Leukemia
- +10 more
- Ziftomenib
- +4 more
- (no location specified)
Feb 17, 2023
Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)
Not yet recruiting
- Lymphoblastic Leukemia
- Dexamethasone
- +8 more
-
Palo Alto, CaliforniaStanford University
Apr 27, 2023